Prostate cancer is a life-altering diagnosis, not just for patients, but for their loved ones as well. Once, prostate cancer was most frequently diagnosed in men in their 60s and 70s; with increasing use of imaging modalities and PSA testing, the incidence is on the rise, and we are now seeing men in their 40s with the disease. This poses a challenge for clinical management depending on the stage of the disease—from watchful waiting or active surveillance to aggressive treatment with the risk of therapeutic nihilism. Despite being one of the most common cancers in Western men, its natural history, prognosis, and treatment are poorly understood. This book brings together a select faculty of experts to present a comprehensive view of the curr...
AbstractCancer of the prostate gland is the highest unavoidable cause of cancer mortality in men. Th...
Prostate cancer is among the most common causes of death from cancer in men, and accounts for 10% of...
The progressive pathway from localized prostate cancer to advanced metastatic disease is one where 2...
Prostate cancer is diagnosed commonly in the course of general health screening. Very often it is di...
Prostate cancer is the second most common cancer affecting men in Europe and the USA. The incidence ...
Prostate cancer is one of the most common types of cancer in men and its treatment was constricted t...
It’s the most common cancer among men. Prostate cancer will affect one in five men at some point in ...
Prostate cancer remains the most common noncutaneous human malignancy, and the second most lethal tu...
Prostate cancer is the most frequently diagnosed male cancer in the world. Like all cancers, prostat...
Prostate cancer is one of the malignancies that affects men and significantly contributes to increas...
If the treatment landscape for prostate cancer is to be transformed, clinicians and scientists must ...
The prostate gland is one of the male organs that have changed over the years. Those changes lead to...
Plain English Summary One in eight men will be diagnosed with prostate cancer (PCa). Most will not d...
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and ther...
textabstractProstate adenocarcinoma is the most frequently diagnosed non-cutaneous male malignancy ...
AbstractCancer of the prostate gland is the highest unavoidable cause of cancer mortality in men. Th...
Prostate cancer is among the most common causes of death from cancer in men, and accounts for 10% of...
The progressive pathway from localized prostate cancer to advanced metastatic disease is one where 2...
Prostate cancer is diagnosed commonly in the course of general health screening. Very often it is di...
Prostate cancer is the second most common cancer affecting men in Europe and the USA. The incidence ...
Prostate cancer is one of the most common types of cancer in men and its treatment was constricted t...
It’s the most common cancer among men. Prostate cancer will affect one in five men at some point in ...
Prostate cancer remains the most common noncutaneous human malignancy, and the second most lethal tu...
Prostate cancer is the most frequently diagnosed male cancer in the world. Like all cancers, prostat...
Prostate cancer is one of the malignancies that affects men and significantly contributes to increas...
If the treatment landscape for prostate cancer is to be transformed, clinicians and scientists must ...
The prostate gland is one of the male organs that have changed over the years. Those changes lead to...
Plain English Summary One in eight men will be diagnosed with prostate cancer (PCa). Most will not d...
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and ther...
textabstractProstate adenocarcinoma is the most frequently diagnosed non-cutaneous male malignancy ...
AbstractCancer of the prostate gland is the highest unavoidable cause of cancer mortality in men. Th...
Prostate cancer is among the most common causes of death from cancer in men, and accounts for 10% of...
The progressive pathway from localized prostate cancer to advanced metastatic disease is one where 2...